| 发明名称 |
PREDICTIVE BIOMARKER FOR CANCER TREATMENT WITH ADCC-ENHANCED ANTIBODIES |
| 摘要 |
The present invention is directed to methods for identifying which patients diagnosed with cancer will most benefit from treatment with an anti-cancer therapy comprising an ADCC-enhanced antibody.
|
| 申请公布号 |
US2013195854(A1) |
申请公布日期 |
2013.08.01 |
| 申请号 |
US201313752468 |
申请日期 |
2013.01.29 |
| 申请人 |
ROCHE GLYCART AG;ROCHE GLYCART AG |
发明人 |
GERDES CHRISTIAN;GIMMI CLAUDE;HOLLINGSWORTH SIMON;MANENTI LUIGI;RUEGER RUEDIGER;UMANA PABLO |
| 分类号 |
G01N33/68;A61K39/395 |
主分类号 |
G01N33/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
